Cardiopulmonary Exercise Testing in Interstitial Lung Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02636452

Enrollment

Registered

2015-12-21

Start date

2013-10-31

Completion date

2017-09-30

Last updated

2018-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Brief summary

In patients with Interstitial lung diseases (ILD) dyspnea is the most often symptom. Pulmonary lung function tests often do not Show the dyspnea. Aim of the study is to evaluate cardiopulmonary exercise testing concerning therapeutic Monitoring in ILD.

Interventions

OTHERcardiopulmonary exercise test

Study design

Observational model

OTHER

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* informed consent provided * ILD

Exclusion criteria

* no informed consent * no ILD

Design outcomes

Primary

Measure	Time frame
Alveolar-arterial oxygen partial pressure difference (AaDO2) in cardipulmonary exercise testing in ILD	quarterly, three years

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026